Stella Pharma Corp. Hits Day High with Strong 7.04% Intraday Surge

Stella Pharma Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 7.04% as of May 21, 2026. The stock reached an intraday high of JPY 452.00, reflecting a notable performance compared to the Japan Nikkei 225, which increased by 3.14% on the same day. Over the past week, Stella Pharma has outperformed the Nikkei 225, with a 7.3% gain versus the index's decline of 1.55%. However, the company's longer-term performance reveals a more complex picture. Over the past month, Stella Pharma's stock has decreased by 29.55%, while the Nikkei 225 has risen by 3.93%. In terms of annual performance, Stella Pharma has generated a return of 30.09%, which is significantly lower than the Nikkei 225's impressive 65.38% return. Year-to-date, the stock has shown a remarkable increase of 117.24%, contrasting with the Nikkei 225's 22.54%. Despite today's gains, the company faces challenges, including a negative return on equity and a history of operating losses, which may impact its future trajectory.